High Mark Wealth Management LLC Royalty Pharma PLC Transaction History

High Mark Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	BUY	$29.6 - $36.56 $621 - $767	21 Added 34.43%	82 $2,000
Q1 2023 Apr 20, 2023	BUY	$32.77 - $39.4 $1,998 - $2,403	61 New	61 $2,000
Q3 2021 Nov 01, 2021	SELL	$36.14 - $42.24 $289 - $337	-8 Reduced 11.11%	64 $2,000
Q2 2021 Aug 02, 2021	SELL	$39.85 - $46.63 $717 - $839	-18 Reduced 20.0%	72 $3,000
Q1 2021 Apr 22, 2021	BUY	$42.34 - $52.82 $973 - $1,214	23 Added 34.33%	90 $4,000
Q4 2020 Jan 27, 2021	BUY	$36.12 - $50.05 $252 - $350	7 Added 11.67%	67 $3,000
Q3 2020 Oct 26, 2020	BUY	$38.56 - $48.36 $2,313 - $2,901	60 New	60 $3,000

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on High Mark Wealth Management LLC with notifications on news.